Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2020-01-03 11:29 am Sale | 13G | TREVENA INC TRVN | SABBY MANAGEMENT LLC | 0 0% | -5,000,000 (Position Closed) | View |
| 2020-01-02 5:12 pm Purchase | 13G | BIOCEPT INC BIOC | SABBY MANAGEMENT LLC | 1,616,055 11% | 1,286,055 (+389.71%) | View |
| 2020-01-02 4:54 pm Purchase | 13G | XTI AEROSPACE INC XTIA | SABBY MANAGEMENT LLC | 1,144,717 11% | 890,021 (+349.44%) | View |
| 2020-01-02 4:12 pm Sale | 13G | KITOV PHARMA LTD SPONSORED ADR KTOV | SABBY MANAGEMENT LLC | 976,070 11% | -738,216 (-43.06%) | View |
| 2020-01-02 3:57 pm Purchase | 13G | CANCER GENETICS INC CGIX | SABBY MANAGEMENT LLC | 24,776 11% | 24,776 (New Position) | View |
| 2019-11-22 09:22 am Purchase | 13G | GENPREX INC GNPX | SABBY MANAGEMENT LLC | 1,584,007 11% | 1,584,007 (New Position) | View |
| 2019-11-22 09:19 am Purchase | 13G | YIELD10 BIOSCIENCE INC YTEN | SABBY MANAGEMENT LLC | 2,275,000 11% | 2,275,000 (New Position) | View |
| 2019-11-22 09:15 am Purchase | 13G | LIPOCINE INC LPCN | SABBY MANAGEMENT LLC | 3,100,000 11% | 2,912,779 (+1555.80%) | View |
| 2019-11-20 2:42 pm Purchase | 13G | APPLIED DNA SCIENCES INC P APDN | SABBY MANAGEMENT LLC | 250,000 11% | 250,000 (New Position) | View |
| 2019-11-14 10:13 am Purchase | 13G | TOP SHIPS INC SHS TOPS | SABBY MANAGEMENT LLC | 850,000 11% | 850,000 (New Position) | View |
| 2019-11-05 09:32 am Purchase | 13G | GUARDION HEALTH SCIENCES INC C GHSI | SABBY MANAGEMENT LLC | 7,200,000 11% | 7,200,000 (New Position) | View |
| 2019-10-08 10:43 am Purchase | 13G | BENITEC BIOPHARMA LT BNTC | SABBY MANAGEMENT LLC | 28,000,000 11% | 19,686,497 (+236.80%) | View |
| 2019-09-27 3:52 pm Purchase | 13G | ONCONOVA THERAPEUTICS INC ONTX | SABBY MANAGEMENT LLC | 733,940 11% | 172,777 (+30.79%) | View |
| 2019-09-23 09:46 am Purchase | 13G | PARETEUM CORP COM TEUM | SABBY MANAGEMENT LLC | 9,375,000 11% | 9,375,000 (New Position) | View |
| 2019-09-04 12:21 pm Purchase | 13G | XENETIC BIOSCIENCES INC PA XBIO | SABBY MANAGEMENT LLC | 253,360 11% | 253,360 (New Position) | View |
| 2019-08-07 12:45 pm Purchase | 13G | TITAN PHARMACEUTICALS INC DEL TTNP | SABBY MANAGEMENT LLC | 1,572,583 11% | 1,572,583 (New Position) | View |
| 2019-08-06 2:56 pm Purchase | 13G | RESHAPE LIFESCIENCES INC C RSLS | SABBY MANAGEMENT LLC | 556,771 11% | 556,771 (New Position) | View |
| 2019-07-22 10:17 am Purchase | 13G | ECOARK HLDGS INC ZEST | SABBY MANAGEMENT LLC | 4,558,340 11% | 4,558,340 (New Position) | View |
| 2019-06-17 10:46 am Purchase | 13G | AMPIO PHARMACEUTICALS INC AMPE | SABBY MANAGEMENT LLC | 8,750,000 11% | 8,750,000 (New Position) | View |
| 2019-06-03 12:14 pm Purchase | 13G | PULMATRIX INC PULM | SABBY MANAGEMENT LLC | 1,008,500 11% | 1,008,500 (New Position) | View |